Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Desmethyl-loperamide is a major active metabolite of the antidiarrheal drug loperamide. It is a synthetic phenylpiperidine opioid that acts as a peripherally selective μ-opioid receptor agonist, similar to its parent compound. Both desmethyl-loperamide and loperamide are substrates of the ATP-dependent efflux transporter P-glycoprotein, which restricts their passage through the blood-brain barrier, limiting central nervous system effects. This metabolite retains activity at peripheral μ-opioid receptors to reduce gastrointestinal motility and fluid secretion, contributing to antidiarrheal effects. It has also been used as a PET radiotracer for imaging P-glycoprotein function due to its transport properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on desmethyl-loperamide.